Akebia Therapeutics, Inc. (AKBA)
1.34
0.00 (0.00%)
USD |
NASDAQ |
Jan 21, 14:14
Akebia Therapeutics Price: 1.34 for Jan. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 339.21 |
| Pfizer Inc. | 25.66 |
| Theravance Biopharma, Inc. | 20.12 |
| Zevra Therapeutics, Inc. | 8.88 |
| Organon & Co. | 9.38 |
Price Related Metrics
| PS Ratio | 1.497 |
| Price to Book Value | 8.549 |
| Price to Free Cash Flow | 10.47 |
| Earnings Yield | -5.68% |
| Market Cap | 355.59M |
| Operating PE Ratio | 18.99 |